Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
The reactive oxygen species (ROS)-mediated mechanism is the major cause underlying the
efficacy of photodynamic therapy (PDT). The PDT procedure is based on the cascade of …
efficacy of photodynamic therapy (PDT). The PDT procedure is based on the cascade of …
[HTML][HTML] GSK-3β in DNA repair, apoptosis, and resistance of chemotherapy, radiotherapy of cancer
J Lin, T Song, C Li, W Mao - … et Biophysica Acta (BBA)-Molecular Cell …, 2020 - Elsevier
Glycogen synthase kinase-3β (GSK-3β) is an evolutionarily conserved serine/threonine
kinase, functioning in numerous cellular processes including cell proliferation, DNA repair …
kinase, functioning in numerous cellular processes including cell proliferation, DNA repair …
[HTML][HTML] DNA repair targeted therapy: The past or future of cancer treatment?
NS Gavande, PS VanderVere-Carozza… - Pharmacology & …, 2016 - Elsevier
The repair of DNA damage is a complex process that relies on particular pathways to
remedy specific types of damage to DNA. The range of insults to DNA includes small …
remedy specific types of damage to DNA. The range of insults to DNA includes small …
[HTML][HTML] Metal-based nanoenhancers for future radiotherapy: radiosensitizing and synergistic effects on tumor cells
Y Liu, P Zhang, F Li, X Jin, J Li, W Chen, Q Li - Theranostics, 2018 - ncbi.nlm.nih.gov
Radiotherapy is one of the major therapeutic strategies for cancer treatment. In the past
decade, there has been growing interest in using high Z (atomic number) elements …
decade, there has been growing interest in using high Z (atomic number) elements …
Scintillating nanoparticles as energy mediators for enhanced photodynamic therapy
Achieving effective treatment of deep-seated tumors is a major challenge for traditional
photodynamic therapy (PDT) due to difficulties in delivering light into the subsurface. Thanks …
photodynamic therapy (PDT) due to difficulties in delivering light into the subsurface. Thanks …
[HTML][HTML] Role of autophagy in cisplatin resistance in ovarian cancer cells
J Wang, GS Wu - Journal of Biological chemistry, 2014 - ASBMB
Cisplatin-based treatment is the first line chemotherapy for several cancers including
ovarian cancer. The development of cisplatin resistance results in treatment failure, but the …
ovarian cancer. The development of cisplatin resistance results in treatment failure, but the …
[PDF][PDF] Cancer causes and treatments
Cancer is a genetic disorder that results from genetic or epigenetic alterations in the somatic
cells and has abnormal cell growth which may be spread to other body parts. In 2018, 18 …
cells and has abnormal cell growth which may be spread to other body parts. In 2018, 18 …
[HTML][HTML] Can cisplatin therapy be improved? Pathways that can be targeted
Cisplatin (cis-diamminedichloroplatinum (II)) is the oldest known chemotherapeutic agent.
Since the identification of its anti-tumour activity, it earned a remarkable place as a treatment …
Since the identification of its anti-tumour activity, it earned a remarkable place as a treatment …
[图书][B] The selection and use of essential medicines: report of the WHO Expert Committee, 2015 (including the 19th WHO Model List of Essential Medicines and the 5th …
Organisation mondiale de la santé. Comité d'experts … - 2015 - books.google.com
This report presents the recommendations of the WHO Expert Committee responsible for
updating the WHO Model Lists of Essential Medicines.. The goal of the meeting was to …
updating the WHO Model Lists of Essential Medicines.. The goal of the meeting was to …
Immune response during therapy with cisplatin or radiation for human papillomavirus–related head and neck cancer
WC Spanos, P Nowicki, DW Lee… - … –head & neck …, 2009 - jamanetwork.com
Background Human papillomavirus (HPV) is the most identifiable cause of head and neck
squamous cell cancer (HNSCC). Compared with HPV-negative HNSCC, HPV-positive …
squamous cell cancer (HNSCC). Compared with HPV-negative HNSCC, HPV-positive …